CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-2.21%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.99B
AUM Growth
+$2.99B
(+30%)
Cap. Flow
+$736M
Cap. Flow
% of AUM
24.63%
Top 10 Holdings %
Top 10 Hldgs %
55.98%
Holding
49
New
7
Increased
18
Reduced
7
Closed
5
Top Buys
| 1 |
Sanofi
SNY
|
$133M |
| 2 |
Universal Health Services
UHS
|
$133M |
| 3 |
Charles River Laboratories
CRL
|
$98.4M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$94.3M |
| 5 |
GSK
GSK
|
$73.6M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$59.3M |
| 2 |
Sarepta Therapeutics
SRPT
|
$38.7M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$34.3M |
| 4 |
Evolent Health
EVH
|
$30.7M |
| 5 |
Incyte
INCY
|
$30M |
Sector Composition
| 1 | Healthcare | 96.56% |
| 2 | Technology | 2.14% |
| 3 | Consumer Discretionary | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dentsply Sirona
XRAY
$2.85B
| $40.1M | 1.23% | 1,415,000 +165,000 | +13% | +$4.68M |
|
|
SGEN
27
DELISTED
Seagen Inc. Common Stock
SGEN
| $34.2M | 1.05% | +250,000 | New | +$34.2M |
|
28
Quanterix
QTRX
$211M
| $33.1M | 1.01% | 3,000,000 +1,858,300 | +163% | +$20.5M |
|
29
ZimVie
ZIMV
$532M
| $25.7M | 0.79% | 2,600,000 +600,000 | +30% | +$5.92M |
|
|
NUVA
30
DELISTED
NuVasive, Inc.
NUVA
| $21.9M | 0.67% | 500,000 | – | – |
|
31
Exelixis
EXEL
$10.1B
| $21.2M | 0.65% | 1,350,000 -300,000 | -18% | -$4.7M |
|
32
Peloton Interactive
PTON
$3.1B
| $20.8M | 0.64% | +3,000,000 | New | +$20.8M |
|
33
Inogen
INGN
$216M
| $20M | 0.61% | 825,000 | – | – |
|
34
Glaukos
GKOS
$5.5B
| $18.6M | 0.57% | 350,000 +162,978 | +87% | +$8.68M |
|
|
CSII
35
DELISTED
Cardiovascular Systems, Inc.
CSII
| $18M | 0.55% | 1,300,000 +359,600 | +38% | +$4.98M |
|
36
Zymeworks
ZYME
$1.12B
| $17.6M | 0.54% | 2,865,000 +865,000 | +43% | +$5.32M |
|
37
Collegium Pharmaceutical
COLL
$1.22B
| $16.8M | 0.52% | 1,050,000 | – | – |
|
38
OraSure Technologies
OSUR
$242M
| $16.1M | 0.49% | 4,250,000 | – | – |
|
|
NSTG
39
DELISTED
NanoString Technologies, Inc.
NSTG
| $12.8M | 0.39% | 1,000,000 +150,000 | +18% | +$1.92M |
|
|
RETA
40
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $12.6M | 0.38% | 500,000 -1,000,000 | -67% | -$25.1M |
|
|
OSH
41
DELISTED
Oak Street Health, Inc.
OSH
| $12.4M | 0.38% | +506,000 | New | +$12.4M |
|
42
Puma Biotechnology
PBYI
$254M
| $10M | 0.31% | 4,235,000 | – | – |
|
|
43
Evolent Health
EVH
$1.12B
| – | – | -1,000,000 | Closed | -$30.7M |
|
44
Exact Sciences
EXAS
$8.98B
| – | – | -300,000 | Closed | -$11.8M |
|
45
Merck
MRK
$210B
| – | – | 0 | – | – |
|
46
Pacific Biosciences
PACB
$393M
| – | – | -424,600 | Closed | -$1.88M |
|
47
Pfizer
PFE
$141B
| – | – | 0 | – | – |
|
|
TSVT
48
DELISTED
2seventy bio
TSVT
| – | – | -48,600 | Closed | -$642K |
|
|
SDC
49
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| – | – | -1,000,000 | Closed | -$1.04M |
|